EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Auto-RS Signature for Prognostic Stratification and Drug Sensitivity Prediction in Osteosarcoma

Qingzhu Liu, Ke Xu, Cong Zhou, Qikui Zhu, Junqin Lu, Yuqiao Tang, Chun Zhang, Wukun Xie, Guojiu Fang, Dasheng Tian, Juehua Jing iD, Yize Li iD und 3 weitere

Genes · 26.06.2026 · 17 (7) · 737

DOI: 10.3390/genes17070737 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 26.06.2026. Verfasst von Qingzhu Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China. Hauptthemen laut MEDLINE: Osteosarcoma, Bone Neoplasms, Biomarkers, Tumor, Drug Resistance, Neoplasm. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation Incubation Program of The Second Affiliated Hospital of Anhui Medical University, Anhui Medical University Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metastasis and poor chemotherapy response have stagnated therapeutic progress in osteosarcoma (OS) for the past three decades. Defining the transition from localized to metastatic OS before overt dissemination is fundamental for improving survival. However, effective early diagnostic tools remain scarce, largely due to limited exploitation of the metastasis-associated tumor microenvironment’s own record of prior environmental and stress exposures encoded in cell-intrinsic transcriptional states. Here, we employed a supervised machine learning framework with iterative resampling and multi-stage model selection to identify molecular markers associated with metastasis in osteosarcoma and to develop a computational signature, Auto-RS.

Methods

Transcriptomic and clinical data from 139 OS patients with ≥5 years of follow-up were analyzed. A LASSO–Cox framework was applied to derive a gene expression-based risk score, Auto-RS, from which a nomogram integrating age and sex was generated for individualized prognosis. Model interpretability was assessed across six independent single-cell OS patient datasets, and drug sensitivity predictions were inferred by integrating Auto-RS with the Precily algorithm to uncover actionable therapeutic vulnerabilities.

Results

Auto-RS, constructed from the expression of four autophagy genes (BNIP3, MYC, PEA15, and SAR1A), served as an independent prognostic factor for overall survival (HR = 1.091; 95% CI, 1.047–1.136; p < 0.001). Time-dependent ROC analysis showed that Auto-RS was the most accurate single predictor (AUC = 0.88), exceeding metastasis (0.83), sex (0.45), and age (0.39). A basic prognostic model (BpM) incorporating metastasis status yielded a C-index of 0.741 (95% CI, 0.679–0.803). The addition of Auto-RS (CpM) improved discrimination (C-index = 0.788; 95% CI, 0.731–0.845), whereas a model without metastasis information (ApM) retained predictive ability (C-index = 0.709; 95% CI, 0.640–0.778). Single-cell analysis confirmed that Auto-RS features aligned with known metastatic trajectories, reflecting the transition from proliferative to invasive tumor states and highlighting coordinated programs among cancer-associated fibroblasts and immune cells. Drug sensitivity integration through Precily identified gemcitabine and cytarabine as FDA-approved agents predicted in silico to show greater sensitivity in the high-risk subgroup.

Conclusions

We identified autophagy-mediated transcriptional ‘stress fingerprints’ that are tightly associated with OS metastasis. The Auto-RS signature, composed of BNIP3, MYC, PEA15, and SAR1A, enables early therapeutic stratification of patients independent of overt metastatic status. Moreover, Auto-RS delineates key molecular underpinnings of OS metastasis at single-cell resolution. As a practical laboratory tool, Auto-RS may represent a step toward improved risk stratification, where advances in metastasis prediction and therapeutic guidance converge to improve outcomes in OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaBone NeoplasmsBiomarkers, TumorDrug Resistance, NeoplasmTranscriptomeHumansPrognosisFemaleMaleGene Expression Regulation, NeoplasticAdultAdolescentGene Expression ProfilingTumor Microenvironment

Stichwörter der Autor:innen

drug sensitivity predictionmachine learningosteosarcomaprognostic biomarkerrisk stratificationsingle-cell analysis

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.
  • Institute of Orthopaedics, Research Center for Translational Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.
  • State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, China.
  • Department of Orthopedics, The First People's Hospital of Lianyungang City, Lianyungang 222061, China.
  • College of Life Sciences, Wuhan University, Wuhan 430072, China.
  • Department of General Surgery, Shanghai Fengxian Central Hospital, Shanghai 201400, China.

ORCID-Profile: Juehua Jing, Yize Li, Yihui Bi

Förderung

  • National Natural Science Foundation of China
  • National Natural Science Foundation Incubation Program of The Second Affiliated Hospital of Anhui Medical University
  • Anhui Medical University Foundation

Zitieren

APA

Liu, Q., Xu, K., Zhou, C., Zhu, Q., Lu, J., Tang, Y., Zhang, C., Xie, W., Fang, G., Tian, D., Jing, J., Li, Y., Duan, W., Wang, H., & Bi, Y. (2026). An Auto-RS Signature for Prognostic Stratification and Drug Sensitivity Prediction in Osteosarcoma. Genes, 17(7), 737. https://doi.org/10.3390/genes17070737

Vancouver

Liu Q, Xu K, Zhou C, Zhu Q, Lu J, Tang Y, et al. An Auto-RS Signature for Prognostic Stratification and Drug Sensitivity Prediction in Osteosarcoma. Genes. 2026;17(7):737. doi:10.3390/genes17070737

BibTeX
@article{Liu2026,
  author = {Liu, Qingzhu and Xu, Ke and Zhou, Cong and Zhu, Qikui and Lu, Junqin and Tang, Yuqiao and Zhang, Chun and Xie, Wukun and Fang, Guojiu and Tian, Dasheng and Jing, Juehua and Li, Yize and Duan, Wenxiu and Wang, Hongsheng and Bi, Yihui},
  title = {An Auto-RS Signature for Prognostic Stratification and Drug Sensitivity Prediction in Osteosarcoma},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {7},
  pages = {737},
  doi = {10.3390/genes17070737}
}
Kostenlos starten →